Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Postoperative cognitive changes after total knee arthroplasty under regional anesthesia.

Jeon YT, Kim BG, Park YH, Sohn HM, Kim J, Kim SC, An SS, Kim S.

Medicine (Baltimore). 2016 Dec;95(52):e5635. doi: 10.1097/MD.0000000000005635.

2.

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Yu Z.

Mol Med Rep. 2016 Oct;14(4):3184-98. doi: 10.3892/mmr.2016.5618. Epub 2016 Aug 9. Review.

3.

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease.

Degerman Gunnarsson M, Ingelsson M, Blennow K, Basun H, Lannfelt L, Kilander L.

Alzheimers Res Ther. 2016 Jun 6;8(1):22. doi: 10.1186/s13195-016-0191-0.

4.

Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.

Ingber AP, Hassenstab J, Fagan AM, Benzinger TL, Grant EA, Holtzman DM, Morris JC, Roe CM.

J Alzheimers Dis. 2016;52(3):1055-64. doi: 10.3233/JAD-150478.

5.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001. Review.

6.

Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment.

Marshall GA, Zoller AS, Lorius N, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DM.

Curr Alzheimer Res. 2015;12(5):493-502.

7.

Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease.

Rueda AD, Lau KM, Saito N, Harvey D, Risacher SL, Aisen PS, Petersen RC, Saykin AJ, Farias ST; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Sep;11(9):1080-9. doi: 10.1016/j.jalz.2014.09.002. Epub 2014 Nov 15.

8.

Should we disclose amyloid imaging results to cognitively normal individuals?

Grill JD, Johnson DK, Burns JM.

Neurodegener Dis Manag. 2013 Feb;3(1):43-51.

9.

Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment.

Marshall GA, Zoller AS, Kelly KE, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DM, For The Alzheimer's Disease Neuroimaging Initiative.

Curr Alzheimer Res. 2014;11(9):853-61.

10.

SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment.

Zoller AS, Gaal IM, Royer CA, Locascio JJ, Amariglio RE, Blacker D, Okereke OI, Johnson KA, Sperling RA, Rentz DM, Marshall GA.

Curr Alzheimer Res. 2014;11(8):785-91.

11.

Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.

Marshall GA, Lorius N, Locascio JJ, Hyman BT, Rentz DM, Johnson KA, Sperling RA.

J Alzheimers Dis. 2014;41(3):719-28. doi: 10.3233/JAD-132768.

12.

CSF biomarkers of Alzheimer disease: "noncognitive" outcomes.

Roe CM, Fagan AM, Grant EA, Holtzman DM, Morris JC.

Neurology. 2013 Dec 3;81(23):2028-31. doi: 10.1212/01.wnl.0000436940.78152.05. Epub 2013 Nov 8.

13.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7. Review.

14.

Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?

Marshall GA, Amariglio RE, Sperling RA, Rentz DM.

Neurodegener Dis Manag. 2012 Oct 1;2(5):483-491.

15.

Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study.

Gabelle A, Richard F, Gutierrez LA, Schraen S, Delva F, Rouaud O, Buée L, Dartigues JF, Touchon J, Lambert JC, Berr C.

J Alzheimers Dis. 2013;33(2):381-91. doi: 10.3233/JAD-2012-121147.

16.

Biomarkers of basic activities of daily living in Alzheimer's disease.

Hall JR, Johnson LA, Barber RC, Vo HT, Winter AS, O'Bryant SE; Texas Alzheimer's Research and Care Consortium.

J Alzheimers Dis. 2012;31(2):429-37. doi: 10.3233/JAD-2012-111481.

17.

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.

Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2013 Jan;34(1):62-72. doi: 10.1016/j.neurobiolaging.2012.03.006. Epub 2012 Apr 13.

18.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2. Review.

19.

Human Alzheimer and inflammation biomarkers after anesthesia and surgery.

Tang JX, Baranov D, Hammond M, Shaw LM, Eckenhoff MF, Eckenhoff RG.

Anesthesiology. 2011 Oct;115(4):727-32. doi: 10.1097/ALN.0b013e31822e9306.

20.

Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

Britschgi M, Rufibach K, Huang SL, Clark CM, Kaye JA, Li G, Peskind ER, Quinn JF, Galasko DR, Wyss-Coray T.

Mol Cell Proteomics. 2011 Oct;10(10):M111.008862. doi: 10.1074/mcp.M111.008862. Epub 2011 Jul 8.

Supplemental Content

Support Center